{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Pharmascope \u00c9pisode 114: Ost\u00e9oporose: solidifier la prise en charge \u2013 partie 2","description":"Holala! Un premier \u00e9pisode du Pharmascope enregistr\u00e9 devant public est maintenant disponible! En direct de Jonqui\u00e8re, S\u00e9bastien, Nicolas et Isabelle continuent leur s\u00e9rie d\u2019\u00e9pisodes sur l\u2019ost\u00e9oporose. Dans cette deuxi\u00e8me partie, on aborde le calcium, la vitamine D ainsi que les diff\u00e9rentes options pharmacologiques dans le traitement de l\u2019ost\u00e9oporose. Les objectifs pour cet \u00e9pisode sont les suivants:  Discuter des avantages et des inconv\u00e9nients \u00e0 la prise de calcium et de vitamine D Expliquer les avantages et les inconv\u00e9nients des traitements pharmacologiques de l\u2019ost\u00e9oporose  &amp;nbsp; Ressources pertinentes en lien avec l\u2019\u00e9pisode Qaseem A et coll; Clinical Guidelines Committee of the American College of Physicians. Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians. Ann Intern Med. 2023;176:224-38. Bolland MJ et coll. Calcium intake and risk of fracture: systematic review. BMJ. 2015;351:h4580. Avenell A, Mak JC, O\u2019Connell D. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men. Cochrane Database Syst Rev. 2014;2014:CD000227. Moe S, Paige A, Allan GM. Osteoporosis in postmenopausal women. Can Fam Physician. 2021;67:346. Nayak S, Greenspan SL. Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis. J Am Geriatr Soc. 2017;65:490-95. National Institute for Health and Care Excellence (NICE). Osteoporosis: assessing the risk of fragility fracture. London; 2017. Papaioannou A et coll. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ. 2010;182:1864-73. Management of Osteoporosis in Postmenopausal Women: The 2021 Position Statement of The North American Menopause Society\u2019\u2019 Editorial Panel. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28:973-97. Calculateur FRAX Centre for Metabolic Bone Diseases. FRAX: Fracture Risk Assessment Tool. University of Sheffield, UK. Outil d\u2019aide \u00e0 la d\u00e9cision Mayo Foundation for Medical Education and Research. Bone Health Choice Decision Aid. Mayo Clinic, USA. ","author_name":"CFPCLearn","author_url":"https:\/\/gomainpro.ca\/practicaltalkspod\/","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/39037590\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/195459555"}